For the roughly one-third of births worldwide now delivered by cesarean section, a quieter downstream consequence may be unfolding in pediatric allergy clinics. Understanding which children face compounded immunological risk at birth — before any symptoms appear — could reshape how clinicians counsel expectant mothers and structure early-life prevention protocols.
This case-control study enrolled 478 children in matched pairs, half diagnosed with allergic rhinitis (AR) and half without. Cesarean delivery appeared in just over half of AR cases versus 35% of controls, yielding an independent odds ratio of 1.92. Maternal history of allergic disease independently contributed an odds ratio of 1.59. Critically, when both factors co-occurred, the interaction was not merely additive — a multiplicative model confirmed a synergistic effect with a combined odds ratio of approximately 5.6, meaning children born via cesarean to atopic mothers faced more than five times the AR risk of unexposed peers.
The biological plausibility here is well-established: cesarean delivery bypasses vaginal microbiome transfer, producing a less diverse neonatal gut microbiota that is known to skew T-helper cell differentiation toward a Th2-dominant, pro-allergic phenotype. Maternal atopy likely contributes a separate genetic and epigenetic predisposition toward IgE-mediated sensitization. The synergy between these two pathways — dysbiotic immune programming compounded by inherited atopic architecture — is biologically coherent and aligns with the hygiene and 'old friends' hypotheses. That said, important limitations apply: this is a single-center case-control design subject to recall bias on maternal delivery history, and residual confounders such as breastfeeding duration, antibiotic exposure, and urban environment were not fully accounted for. The finding is confirmatory of prior directional evidence but strengthens the quantified interaction term. Clinically, it reinforces the case for targeted microbiome-supportive interventions — including probiotic supplementation and early allergen exposure — specifically for cesarean-born infants of atopic mothers.